Home » Stocks » Second Sight Medical Products

Second Sight Medical Products, Inc. (EYES)

Stock Price: $0.838 USD -0.032 (-3.72%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $0.815 -0.023 (-2.69%) Oct 21, 5:26 PM

Stock Price Chart

Key Info

Market Cap 19.36M
Revenue (ttm) 969,000
Net Income (ttm) -27.44M
Shares Out 23.12M
EPS (ttm) -1.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $0.838
Previous Close $0.870
Change ($) -0.032
Change (%) -3.72%
Day's Open 0.863
Day's Range 0.797 - 0.870
Day's Volume 249,125
52-Week Range 0.691 - 7.600

More Stats

Market Cap 19.36M
Enterprise Value 15.86M
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 23.12M
Float 12.60M
EPS (basic) -1.72
EPS (diluted) -1.63
FCF / Share -1.40
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 491,348
Short Ratio 1.02
Short % of Float 3.90%
Beta 2.02
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 19.98
PB Ratio 10.27
Revenue 969,000
Operating Income -27.77M
Net Income -27.44M
Free Cash Flow -28.40M
Net Cash 3.51M
Net Cash / Share 0.15
Gross Margin 126.63%
Operating Margin -2,865.33%
Profit Margin -2,831.60%
FCF Margin -2,930.34%
ROA -87.67%
ROE -235.74%
ROIC 3,482.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.00*
Low
10.0
Current: $0.838
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue3.386.907.963.998.953.401.571.37
Revenue Growth-51%-13.41%99.85%-55.47%163.39%117.12%14.47%-
Gross Profit1.232.012.85-6.093.66-0.16-4.06-3.03
Operating Income-33.95-35.18-28.61-33.21-20.05-21.23-18.00-16.02
Net Income-33.59-35.09-28.52-33.18-20.02-35.20-22.97-16.28
Shares Outstanding14.718.306.774.944.453.132.822.74
Earnings Per Share-2.28-4.23-4.24-6.72-4.48-11.28-8.16-5.92
Operating Cash Flow-27.63-29.81-23.95-25.07-20.55-17.09-17.43-15.32
Capital Expenditures-0.49-0.16-0.27-0.49-0.76-0.56-0.25-0.20
Free Cash Flow-28.12-29.97-24.21-25.56-21.31-17.65-17.67-15.52
Cash & Equivalents11.334.477.8410.8815.9634.628.67-
Total Debt2.60-----19.21-
Net Cash / Debt8.734.477.8410.8815.9634.62-10.54-
Assets16.6010.6814.5016.8128.2543.0712.67-
Liabilities9.327.606.625.667.988.4521.89-
Book Value7.283.087.8811.1520.2634.62-9.22-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Second Sight Medical Products, Inc.
Country United States
Employees 11
CEO Matthew J. Pfeffer

Stock Information

Ticker Symbol EYES
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: EYES
IPO Date November 19, 2014

Description

Second Sight Medical Products develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.